Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (Q57943255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10776741%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10776741%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

1 reference

language of work or name

English

0 references

publication date

April 2000

0 references

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10776741%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

number of pages

8

1 reference

inferred from page(s)

published in

The Lancet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10776741%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10776741%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

9212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10776741%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

1295-1302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10776741%20AND%20SRC:MED&resulttype=core&format=json

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Deep venous thrombosis: a continuing problem

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Postoperative pulmonary embolism after hospital discharge. An underestimated risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Antiplatelet treatment for thromboprophylaxis: a step forward or backwards?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Orthopaedic surgeons and thromboprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Physician practices in the prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Trials: the next 50 years. Large scale randomised evidence of moderate benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Allocation of patients to treatment groups in a controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Cumulative antiplatelet effect of low-dose enteric coated aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Drugs in the peri-operative period: 4--Cardiovascular drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902110-3

7 January 2021

10.1016/S0140-6736(00)02110-3

Identifiers

DOI

0 references

1 reference